| 000 | 01750 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513033436.0 | ||
| 264 | 0 | _c19951228 | |
| 008 | 199512s 0 0 eng d | ||
| 022 | _a0021-972X | ||
| 024 | 7 |
_a10.1210/jcem.80.11.7593444 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldfine, A B | |
| 245 | 0 | 0 |
_aMetabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. _h[electronic resource] |
| 260 |
_bThe Journal of clinical endocrinology and metabolism _cNov 1995 |
||
| 300 |
_a3311-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xdrug therapy |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aIslets of Langerhans _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMitogen-Activated Protein Kinase 1 |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xblood |
| 650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xblood |
| 650 | 0 | 4 | _aRibosomal Protein S6 Kinases |
| 650 | 0 | 4 |
_aVanadates _xadverse effects |
| 700 | 1 | _aSimonson, D C | |
| 700 | 1 | _aFolli, F | |
| 700 | 1 | _aPatti, M E | |
| 700 | 1 | _aKahn, C R | |
| 773 | 0 |
_tThe Journal of clinical endocrinology and metabolism _gvol. 80 _gno. 11 _gp. 3311-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1210/jcem.80.11.7593444 _zAvailable from publisher's website |
| 999 |
_c7592883 _d7592883 |
||